Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/13854
Macroloides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
Año del Documento
Journal of Infection Developing Countries 2009; 3(3):159-161.
The current outburst of a new H1N1 swine influenza strain(s) in México and the United States is causing great concern in health authorities and in the general population . With the World Health Organization (WHO) reporting the pandemic potential of the new strain, it is necessary to determine which therapeutic options are available until a specific vaccine is available. Based on information from the Centre for Disease Control (CDC), the virus is sensitive to oseltamivir and zanamivir. Antivirals are strongly affected by viral mutations; thus their efficiency could be lost as the virus changes.
Gripe - Vacunas
Revisión por pares
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International